Endocrine, Metabolic and Immune Disorders - Drug Targets
Impact Factor & Key Scientometrics

Endocrine, Metabolic and Immune Disorders - Drug Targets
Overview

Impact Factor

2.895

H Index

55

Impact Factor

2.311

I. Basic Journal Info

Country

United Arab Emirates
Journal ISSN: 18715303
Publisher: Bentham Science Publishers
History: 2006-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

II. Science Citation Report (SCR)



Endocrine, Metabolic and Immune Disorders - Drug Targets
SCR Impact Factor

Endocrine, Metabolic and Immune Disorders - Drug Targets
SCR Journal Ranking

Endocrine, Metabolic and Immune Disorders - Drug Targets
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

0.518

Endocrine, Metabolic and Immune Disorders - Drug Targets
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Endocrine, Metabolic and Immune Disorders - Drug Targets
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Endocrine, Metabolic and Immune Disorders - Drug Targets
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Endocrine, Metabolic and Immune Disorders - Drug Targets
Impact Factor History

2-year 3-year 4-year
  • 2022 Impact Factor
    1.966 2.056 2.218
  • 2021 Impact Factor
    2.311 2.57 2.496
  • 2020 Impact Factor
    2.731 2.694 2.656
  • 2019 Impact Factor
    2.017 1.796 2.176
  • 2018 Impact Factor
    1.282 2.032 2.067
  • 2017 Impact Factor
    1.965 2.238 1.959
  • 2016 Impact Factor
    2.149 1.992 2.188
  • 2015 Impact Factor
    2.048 2.439 2.452
  • 2014 Impact Factor
    1.771 NA NA
  • 2013 Impact Factor
    2.528 NA NA
  • 2012 Impact Factor
    1.671 NA NA
  • 2011 Impact Factor
    2.13 NA NA
  • 2010 Impact Factor
    3.212 NA NA
  • 2009 Impact Factor
    2.582 NA NA
  • 2008 Impact Factor
    2.766 NA NA
  • 2007 Impact Factor
    2.495 NA NA
  • 2006 Impact Factor
    2.349 NA NA
  • 2005 Impact Factor
    2.358 NA NA
  • 2004 Impact Factor
    1.98 NA NA
  • 2003 Impact Factor
    1.644 NA NA
  • 2002 Impact Factor
    0.591 NA NA
  • 2001 Impact Factor
    0 NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Endocrine, Metabolic and Immune Disorders - Drug Targets
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

55

Endocrine, Metabolic and Immune Disorders - Drug Targets
H-Index History